Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

about

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

Item

http://www.wikidata.org/entity/Q54355027

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@en

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@nl

type

Item

label

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@en

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@nl

prefLabel

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@en

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@nl

P1476

Vascular Anomalies: From a Clinicohistologic to a Genetic Framework.

@en

P2093

Arin K Greene

http://www.w3.org/2001/XMLSchema#string

Jeremy A Goss

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome

Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas")

Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

BMP9 mutations cause a vascular-anomaly syndrome with phenotypic overlap with hereditary hemorrhagic telangiectasia

Mutations in CCBE1 cause generalized lymph vessel dysplasia in humans

Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations

Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.

P304

709e-717e

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PRS.0000000000004294

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29697621

http://www.w3.org/2001/XMLSchema#string

P932

5922803

http://www.w3.org/2001/XMLSchema#string